Kyverna Therapeutics, Inc. (KYTX)
8.68
-0.48
(-5.24%)
USD |
NASDAQ |
Jan 15, 12:15
Kyverna Therapeutics EPS Diluted (Quarterly): -0.8473 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.133 |
| CorMedix, Inc. | 1.259 |
| Castle Biosciences, Inc. | -0.0172 |
| Vistagen Therapeutics, Inc. | -0.5432 |
| Ocugen, Inc. | -0.066 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.79M |
| Total Expenses (Quarterly) | 36.79M |
| Enterprise Value | 235.06M |
| Earnings Yield | -42.87% |
| Normalized Earnings Yield | -42.87 |